Sedia Biosciences develops and sells medical diagnostic tests and monitoring tools used to battle against pandemics.
It is Sedia's mission to provide more cost effective and accessible diagnostic testing by advancing the widespread use of innovative surveillance and monitoring tools, and point-of-care diagnostic testing.Our objectives are to become a leader in advancing access to medical care by (1) focusing on point-of-care diagnostics and (2) developing innovative diagnostic, surveillance and monitoring tools that enable more cost effective deployment of resources by healthcare providers.With headquarters in Portland, Oregon, USA, Sedia brings together a dedicated team of researchers and scientists that share our common mission - to improve access to medical care around the world by providing innovative diagnostic products.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 30, 2016 | Grant | $1.80M | 1 | — | — | Detail |
Aug 19, 2014 | Grant | $200K | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | — | Grant |